In vivo differentiation of magnetically labeled mesenchymal stem cells into hepatocytes for cell therapy to repair damaged liver

Investigative Radiology

Volumn 45, Issue 10, 2010, Pages 625-633

  Ju, Shenghong ^a   Teng, Gao Jun ^a   Lu, Haihua ^a   Jin, Jiyang ^a   Zhang, Yu ^a   Zhang, Aifeng ^a   Ni, Yicheng ^a,b  

^a SOUTHEAST UNIVERSITY   (China)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

differentiation; labeling; magnetic nanoparticles; magnetic resonance imaging; mesenchymal stem cells; transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; FERRIC OXIDE; GREEN FLUORESCENT PROTEIN; MAGNETIC NANOPARTICLE; POLYLYSINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DIFFERENTIATION; CELL LABELING; CELL MIGRATION; CELL THERAPY; CONTROLLED STUDY; HISTOLOGY; LIVER CELL; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION; MESENCHYMAL STEM CELL; MOUSE; MUSCLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 77957275865     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181ed55f4     Document Type: Article

References (52)

1. Allen KJ, Soriano HE. Liver cell transplantation: the road to clinical application [review]. J Lab Clin Med. 2001;138:298-312.
2. Okamoto R, Yajima T, Yamazaki M, et al. Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med. 2002;8:1011-1017.
3. Korbling M, Katz RL, Khanna A, et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med. 2002;346:738-746.
4. Avital I, Inderbitzin D, Aoki T, et al. Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells. Biochem Biophys Res Commun. 2001;288:156-164.
5. Schwartz RE, Reyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest. 2002;109:1291-1302. (Pubitemid 34546893)
6. Wang PP, Wang JH, Yan ZP, et al. Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF inductions. Biochem Biophys Res Commun. 2004;320:712-716.
7. Lee KD, Kuo TK, Whang-Peng J, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology. 2004;40:1275-1284.
8. Yamamoto N, Terai S, Ohata S, et al. A subpopulation of bone cells depleted by a novel antibody, anti-Liv8, is useful for cell therapy to repair damaged liver. Biochem Biophys Res Commun. 2004;313:1110-1118.
9. Sato Y, Araki H, Kato J, et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood. 2005;106:756-763.
10. Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998;279:1528-1530.
11. Mezey E, Chandross KJ, Harta G, et al. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science. 2000;290:1779-1782.
12. Orlic D, Kajstura J, Chimenti S, et al. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci. 2001;938:221-229.
13. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105: 369-377.
14. Wagers AJ, Sherwood RI, Christensen JL, et al. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 2002; 297:2256-2259.
15. Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived stem cells. Blood. 2003;102:3483-3493.
16. Unger EC. How can superparamagnetic iron oxides be used to monitor disease and treatment? Radiology. 2003;229:615-616.
17. Modo M, Cash D, Mellodew K, et al. Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage. 2002;17:803-811.
18. Bulte JW, Zhang S, van Gelderen P, et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci USA. 1999;96:15256-15261.
19. Hill JM, Dick JA, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation. 2003;108: 1009-1014.
20. Ju S, Teng GJ, Lu H, et al. In vivo MR tracking of mesenchymal stem cells in rat liver after intrasplenic transplantation. Radiology. 2007;245:206-215.
21. Sun JH, Teng GJ, Ju SH, et al. MR tracking of magnetically labeled mesenchymal stem cells in rat kidneys with acute renal failure. Cell Transplant. 2008;17:279-290.
22. Ju S, Teng G, Zhang Y, et al. In vitro labeling and MRI of mesenchymal stem cells from human umbilical cord blood. Magn Reson Imaging. 2006;24:611-617. (Pubitemid 43776561)
23. Mai XL, Ma ZL, Sun JH, et al. Assessments of proliferation capacity and viability of New Zealand rabbit peripheral blood endothelial progenitor cells labeled with superparamagnetic particles. Cell Transplant. 2009;18:171-181.
24. Arbab AS, Yocum GT, Kalish H, et al. Ferumoxides-protamine sulfate labeling does not alter differentiation of mesenchymal stem cells. Blood. 2004;104:3412-3413.
25. Matuszewski L, Persigehl T, Wall A, et al. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size and surface coating on labeling efficiency. Radiology. 2005;235:155-161.
26. Focke A, Schwarz S, Foerschler A, et al. Labeling of human neural precursor cells using ferromagnetic nanoparticles. Magn Reson Med. 2008;60:1321-1328.
27. Tran DN, Ota LC, Jacobson JD, et al. Influence of nanoparticles on morphological differentiation of mouse embryonic stem cells. Fertil Steril. 2007;87: 965-970.
28. Ma M, Zhang Y, Yu W, et al. Preparation and characterization of magnetite nanoparticles coated by amino silane. Colloids Surf A: Physicochem Eng Aspects. 2003;212:219-226.
29. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71-74.
30. Recknagel RO, Glende EA, Dolak JA, et al. Mechanism of CCl4 toxicity. Pharmacol Ther. 1989;43:139-154.
31. Wolff S, Balaban R. Assessing contrast on MR images. Radiology. 1997; 202:25-29.
32. Chevallier M, Guerve S, Chossegros P, et al. A histological semiquanitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology. 1994;20: 349-355.
33. 3 nanoparticles on CHL cells in vitro [in Chinese]. Chin J Public Health. 2005;21:589-591.
34. Bulte JW, Zhang SC, van Gelderen P, et al. Magnetically labeled glial cells as cellular MR contrast agents. Acad Radiol. 2002;9(suppl 1):S148-S150.
35. Hung SC, Deng WP, Yang WK, et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res. 2005;11:7749-7756.
36. Shichinohe H, Kuroda S, Lee JB, et al. In vivo tracking of bone marrow stromal cells transplanted into mice cerebral infarct by fluorescence optical imaging. Brain Res Brain Res Protoc. 2004;13:166-175.
37. Daldrup-Link HE, Rudelius M, Oostendorp RA, et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology. 2003;228:760-767.
38. Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology. 2003;228:480-487.
39. Zhu J, Zhou L, XingWu F. Tracking neural stem cells in patients with brain trauma. N Engl J Med. 2006;355:2376-2378.
40. De Vries IJ, Lesterhuis WJ, Barentsz JO, et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol. 2005;23:1407-1413.
41. Bos C, Delmas Y, Desmouliere A, et al. In vivo MR imaging of intravascu-larly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology. 2004;233:781-789.
42. Arbab AS, Jordan EK, Wilson LB, et al. In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum Gene Ther. 2004;15:351-360.
43. Gao J, Dennis JE, Muzic RF, et al. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs. 2001;169:12-20.
44. Aicher A, Brenner W, Zuhayra M, et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation. 2003;107:2134-2139.
45. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 2003;422:897-901.
46. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature. 2003;422:901-904.
47. Wang X, Ge S, McNamara G, et al. Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood. 2003;101:4201-4208.
48. Kanazawa Y, Verma IM. Little evidence of bone marrow derived hepatocytes in the replacement of injured liver. Proc Natl Acad Sci USA. 2003;100: 11850-11853.
49. Park KI, Teng YD, Snyder EY. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol. 2002;20:1111-1117.
50. Ourednik J, Ourednik V, Lynch WP, et al. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol. 2002;20:1103-1110.
51. Hess D, Li L, Martin M, et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol. 2003;21:763-770.
52. Fang B, Shi M, Liao L, et al. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation. 2004;78:83-88.